Friday, 17 Aug 2018

You are here

Increased Risk of Depression and Anxiety in Rheumatoid Arthritis

Canadian researchers have analyzed population data and shown that the incidence and prevalence of depression, anxiety  and bipolar disorders are elevated in the rheumatoid arthritis (RA) patients compared to a matched population.

Estimates on the prevalence of depression and anxiety in RA patients vary widely in the literature. Thus, investigators analyzed population‐based administrative health data from Manitoba, Canada, to identify RA patients and a 5:1 matched control population to estimate the incidence and prevalence of depression, anxiety disorder, bipolar disorder, and schizophrenia. 

Among 10,206 incident cases of RA and 50,960 matched individuals, adjusted incidence rates were reported:

  • Depression: was higher in the RA patients (incidence rate ratio [IRR] 1.46 [95% confidence interval (95% CI) 1.35–1.58]). The lifetime and annual period prevalence of depression was also higher in RA.
  • Anxiety: was higher in RA patients (IRR 1.24 [95% CI 1.15–1.34]). The lifetime and annual period prevalence of anxiety was also higher in RA 
  • Bipolar disorder was also higher (IRR 1.21 [95% CI 1.00–1.47]).
  • Not significant: the frequency of schizophrenia did not differ between groups (IRR 0.96 [95% CI 0.61–1.50]).

The risks of depression, anxiety disorder, and bipolar disorder have not changed over time, despite substantial changes in the clinical management of RA over the 20‐year study period.

Clinicians should be aware that women and those of lower socioeconomic status are at particularly increased risk of these disorders.


The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Early Exposure to Passive Smoke May Up Risk for RA Later in Life

Exposure to second-hand smoke during childhood was associated with an increased risk for developing rheumatoid arthritis (RA) later in life, researchers said.

Tumor Necrosis Factor Inhibitors Do Not Increase the Risk of Cancer Recurrence

There is a large body of data that shows tumor necrosis factor inhibitors (TNFi) use in rheumatoid arthritis (RA) confers the same risk as that seen in RA - meaning there is no increase over and above that incurred by inflammation and RA itself.  There are fewer studies about whether it is safe to use a TNFi in someone with a pre-existing history of cancer.

Cardiovascular Benefits of Maintaining Biologic Therapy

An Australian prospective study of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) has shown that sustained use of tumour necrosis factor (TNFi) inhibitors or biologics can reduce the risks of cardiovascular events (CVEs).

Maternal RA Increases Offspring Risk of Autoimmune Disorders

A Danish population study suggests that fetal exposure to maternal rheumatoid arthritis results in an increased offspring risk of thyroid disease, epilepsy and RA, compared to children born to mothers without RA.

The Fate of Palindromic Rheumatism


Palindromic rheumatism (PR) is an intermittent inflammatory arthropathy with episodes of arthritis and/or periarticular inflammation that wax and wane over time. It is thought that up to one-third of such patients may go on to develop rheumatoid arthritis (RA).